borderline significantp =0.06
(2017) examining chemotherapy toxicities in individuals with advanced or metastatic breast cancer calculated SMG and noted low SMG was predictive of grade 3–4 toxicities during cycles 1 to 3 ( p = 0.04), and hospitalization ( p =0.01), and was borderline significant for any adverse event ( p =0.06).